IPSEN LTD
Ipsen Ltd is the UK subsidiary of
Ipsen, a European pharmaceutical group with over
20 products on the market and a total worldwide staff of
nearly 4000.
Ipsen's development strategy is based on a combination
of products in targeted therapeutic areas - oncology,
endocrinology and neuromuscular disorders - which are
growth drivers, and primary care products which contribute
significantly to its research financing. This strategy is also
supported by an active policy of partnerships.
Ipsen Ltd's Endocrinology and Oncology Business Unit is
responsible for a portfolio of products with sophisticated
sustained release delivery systems for the management of
various hormone-related diseases.
Ipsen's R&D programme is based on four technological
platforms: peptide engineering, protein engineering,
medicinal chemistry and advanced drug delivery. The
location of its four R&D centres (Paris, Boston, Barcelona and
London) gives the group a competitive edge in gaining
access to leading university research teams and highly
qualified personnel. Nearly 700 people in R&D are dedicated
to the discovery and development of innovative drugs for
patient care.
Ipsen Ltd, 190 Bath Road, Slough SL1 3XE, UK
Tel: 01753-627777
Fax: 01753-627778
http://www.ipsen.co.uk